7218936

CD9 Monoclonal Antibody (eBioSN4 (SN4 C3-3A2)), eBioscience™, Invitrogen™

Mouse Monoclonal Antibody

Manufacturer: Fischer Scientific

The price for this product is unavailable. Please request a quote

Antigen

CD9

Concentration

0.5 mg/mL

Classification

Monoclonal

Form

Liquid

Regulatory Status

RUO

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Alias

5H9; 5H9 antigen; antigen CD9; BA2; BA-2/p24 antigen; BTCC-1; CD9; CD9 antigen; CD9 antigen (p24); CD9 molecule; cell growth-inhibiting gene 2 protein; DRAP-27; GIG2; Leukocyte antigen MIC3; MIC3; motility related protein-1; Motility-related protein; MRP-1; p24; sCD 9; sCD9; soluble CD 9; soluble CD9; Tetraspanin29; Tetraspanin-29; transmembrane protein CD9; TSPAN29; Tspan-29

Gene Symbols

CD9

Primary or Secondary

Primary

Content And Storage

4° C

Gene

CD9

Clone

eBioSN4 (SN4 C3-3A2)

Applications

Flow Cytometry, Immunohistochemistry (Frozen), Immunoprecipitation

Conjugate

Unconjugated

Host Species

Mouse

Target Species

Human

Gene Accession No.

P21926

Gene ID (Entrez)

928

Isotype

IgG1 κ

Purification Method

Affinity chromatography

Product Type

Antibody

Related Products

Img

Fischer Scientific

7229455

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7218705

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7222831

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7218758

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7218758

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7218974

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7218902

Mouse Monoclonal Antibody...

Img

Fischer Scientific

7218902

Mouse Monoclonal Antibody...

Description

  • The eBioSN4 MAb reacts with human CD9
  • CD9 is a 24 kDa member of the tetraspanin family, whose members are characterized by the presence of 4 hydrophobic transmembrane domains
  • CD9 is expressed in platelets, eosinophils, basophils, pre-B cells, activated T cells and neural cell lines
  • Furthermore, CD9 expression has been associated with a malignant phenotype, including expression on 90% of non T cell acute lymphoblastic leukemia cells and on 50% of chronic lymphocytic and acute myeloblastic leukemias
  • In platelets, CD9 is expressed in alpha-granules and through association with the integrin alphaIIb/betaIII plays a role in platelet aggregation, as demonstrated by the use of anti-human CD9 antibodies
  • CD9 has also been shown to induce the aggregation of pre-B cell lines, and the adhesion and migration of pre-B cells and Schwann cells
  • Additionally, it has been demonstrated that CD9 is able to provide a co-stimulatory signal for T cells independently of CD28, in the absence of antigen-presenting cells
  • Binding of the eBioSN4 MAb partially cross-blocks binding of another anti-human CD9 MAb, MM2/57
  • CD9 antigen is a glycoprotein expressed on the surface of developing B lymphocytes, platelets, monocytes, eosinophils, basophil, stimulated T lymphocytes and by neurons and glial cells in the peripheral nervous system
  • CD9 belongs to a family of membrane proteins termed tetraspanins which transverse the membrane four times
  • In pre B cells and platelets, CD9 antigen regulates cell activation and aggregation possibly through an association with the integrin CD41 / CD61 (GPIIb / GPIIIa)
  • CD9 is involved in cell motility, osteoclastogenesis, neurite outgrowth, myotube formation, and sperm-egg fusion, plays roles in cell attachment and proliferation and is necessary for association of heterologous MHC II molecules on the dendritic cell plasma membrane which is important for effective T cell stimulation
  • CD9 functions in many cellular processes including differentiation, adhesion, and signal transduction, and expression plays a critical role in the suppression of cancer cell motility and metastasis
  • CD9 is also considered as metastasis suppressor in solid tumors.